Yong Xu

机构：Nanjing University of Chinese Medicine, Central South University, Nanjing Drum Tower Hospital, Zhuzhou Central Hospital, Nagasaki University, East China Normal University · ORCID：0000-0001-5889-1094

发表论文 59 篇 · 总被引 1052 次 · h-index 15

代表论文

• Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma (2022 · Frontiers in Genetics · 被引 106)
• Screening Biomarkers for Systemic Lupus Erythematosus Based on Machine Learning and Exploring Their Expression Correlations With the Ratios of Various Immune Cells (2022 · Frontiers in Immunology · 被引 52)
• Intracellular hydrogelation of macrophage conjugated probiotics for hitchhiking delivery and combined treatment of colitis (2023 · Materials Today Bio · 被引 26)
• A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment (2022 · Frontiers in Immunology · 被引 18)
• The novel m6A writer METTL5 as prognostic biomarker probably associating with the regulation of immune microenvironment in kidney cancer (2022 · Heliyon · 被引 17)
• Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs (2022 · Frontiers in Immunology · 被引 15)